NA Disposable Peripheral Capillary OXygen Saturation (SPO2) Sensor Market

TABLE OF CONTENT

TABLE OF CONTENTS
1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 28
1.3 OVERVIEW OF NORTH AMERICA DISPOSABLE PERIPHERAL CAPILLARY OXYGEN SATURATION (SPO2) SENSOR MARKET 28
1.4 CURRENCY AND PRICING 30
1.5 LIMITATIONS 30
1.6 MARKETS COVERED 30
2 MARKET SEGMENTATION 33
2.1 MARKETS COVERED 33
2.2 GEOGRAPHICAL SCOPE 34
2.3 YEARS CONSIDERED FOR THE STUDY 35
2.4 DBMR TRIPOD DATA VALIDATION MODEL 36
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 39
2.6 DBMR MARKET POSITION GRID 40
2.7 VENDOR SHARE ANALYSIS 41
2.8 MULTIVARIATE MODELING 42
2.9 TYPE TIMELINE CURVE 42
2.10 MARKET APPLICATION COVERAGE GRID 43
2.11 SECONDARY SOURCES 44
2.12 ASSUMPTIONS 44
3 EXECUTIVE SUMMARY 45
4 PREMIUM INSIGHTS 48
5 PORTER 50
6 REGULATORY FRAMEWORK 51
7 MARKET OVERVIEW 52
7.1 DRIVERS 54
7.1.1 RISE IN ADOPTION OF REUSABLE SPO2 SENSOR 54
7.1.2 RISING DEMAND FOR SPO2 SENSORS WITH ARTIFICIAL INTELLIGENCE 54
7.1.3 GROWING NUMBER OF HOSPITALS AND HEALTHCARE CLINICS 55
7.1.4 INCREASING PREVALENCE OF RESPIRATORY DISEASES 55
7.2 RESTRAINTS 56
7.2.1 SHORTAGE IN THE SUPPLY OF SPO2 SENSORS 56

7.3 CHALLENGES 56
7.3.1 LACK OF SKILLED LABOURER 56
7.3.2 TECHNICAL CHALLENGS AND HIGH COST OF END PRODUCTS 57
7.3.3 CHIP SUPPLY SHORTAGE 57
7.3.4 NEED FOR HIGH MAINTENANCE OF SOFTWARE 58
7.4 OPPORTUNITIES 58
7.4.1 SHIFTING CONSUMER PREFERENCE TOWARDS PORTABLE SPO2 SENSORS 58
7.4.2 SURGE IN SENSOR APPLICATIONS AND RELATED EQUIPMENTS IN HOSPITALS 59
8 NORTH AMERICA DISPOSABLE PERIPHERAL CAPILLARY OXYGEN SATURATION (SPO2) SENSOR MARKET, BY CONNECTOR 60
8.1 OVERVIEW 61
8.2 LESS THAN 6 PINS 62
8.3 6 PINS  10 PINS 62
8.4 MORE THAN 10 PINS 63
9 NORTH AMERICA DISPOSABLE PERIPHERAL CAPILLARY OXYGEN SATURATION (SPO2) SENSOR MARKET, BY USAGE 65
9.1 OVERVIEW 66
9.2 ADULT 67
9.3 PEDIATRIC 67
9.4 NEONATE 68
9.5 ANIMAL 69
9.6 OTHERS 70
10 NORTH AMERICA DISPOSABLE PERIPHERAL CAPILLARY OXYGEN SATURATION (SPO2) SENSOR MARKET, BY TECHNIQUE 71
10.1 OVERVIEW 72
10.2 REFLECTANCE 73
10.3 TRANSFLECTANCE 73
11 NORTH AMERICA DISPOSABLE PERIPHERAL CAPILLARY OXYGEN SATURATION (SPO2) SENSOR MARKET, BY SIGNAL 75
11.1 OVERVIEW 76
11.2 ANALOG 77
11.3 DIGITAL 77

12 NORTH AMERICA DISPOSABLE PERIPHERAL CAPILLARY OXYGEN SATURATION (SPO2) SENSOR MARKET, BY APPLICATION 79
12.1 OVERVIEW 80
12.2 FINGER 81
12.3 EAR 81
12.4 FOOT 82
12.5 TOE 83
12.6 MULTI POSITION 83
12.7 OTHERS 84
13 NORTH AMERICA DISPOSABLE PERIPHERAL CAPILLARY OXYGEN SATURATION (SPO2) SENSOR MARKET, BY END USER 86
13.1 OVERVIEW 87
13.2 CLINICAL 88
13.3 HOSPITAL 88
13.4 VETERINARY 89
13.5 OTHERS 89
14 NORTH AMERICA DISPOSABLE PERIPHERAL CAPILLARY OXYGEN SATURATION (SPO2) SENSOR MARKET, BY SALES CHANNEL 91
14.1 OVERVIEW 92
14.2 OFFLINE 93
14.3 ONLINE 93
14.4 COMPANY WEBSITE 94
14.5 E-COMMERCE 94
15 NORTH AMERICA DISPOSABLE PERIPHERAL CAPILLARY OXYGEN SATURATION (SPO2) SENSOR MARKET, BY REGION 95
15.1 NORTH AMERICA 96
15.1.1 U.S. 104
15.1.2 CANADA 106
15.1.3 MEXICO 108
16 NORTH AMERICA DISPOSABLE PERIPHERAL CAPILLARY OXYGEN SATURATION (SPO2) SENSOR MARKET: COMPANY LANDSCAPE 110
16.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 110
17 SWOT ANALYSIS 111

18 COMPANY PROFILE 112
18.1 MEDTRONIC 112
18.1.1 COMPANY SNAPSHOT 112
18.1.2 REVENUE ANALYSIS 112
18.1.3 COMPANY SHARE ANALYSIS 113
18.1.4 PRODUCT PORTFOLIO 113
18.1.5 RECENT DEVELOPMENT 113
18.2 TE CONNECTIVITY 114
18.2.1 COMPANY SNAPSHOT 114
18.2.2 REVENUE ANALYSIS 114
18.2.3 COMPANY SHARE ANALYSIS 115
18.2.4 PRODUCT PORTFOLIO 115
18.2.5 RECENT DEVELOPMENT 115
18.3 GENERAL ELECTRIC COMPANY 116
18.3.1 COMPANY SNAPSHOT 116
18.3.2 COMPANY SHARE ANALYSIS 116
18.3.3 PRODUCT PORTFOLIO 116
18.3.4 RECENT DEVELOPMENT 117
18.4 NIHON KOHDEN CORPORATION 118
18.4.1 COMPANY SNAPSHOT 118
18.4.2 REVENUE ANALYSIS 118
18.4.3 COMPANY SHARE ANALYSIS 119
18.4.4 PRODUCT PORTFOLIO 119
18.4.5 RECENT DEVELOPMENTS 120
18.5 MASIMO 121
18.5.1 COMPANY SNAPSHOT 121
18.5.2 REVENUE ANALYSIS 121
18.5.3 COMPANY SHARE ANALYSIS 122
18.5.4 PRODUCT PORTFOLIO 122
18.5.5 RECENT DEVELOPMENTS 123
18.6 AVANTE 125
18.6.1 COMPANY SNAPSHOT 125
18.6.2 PRODUCT PORTFOLIO 125
18.6.3 RECENT DEVELOPMENT 125
18.7 CRITICARE TECHNOLOGIES, INC. 126
18.7.1 COMPANY SNAPSHOT 126
18.7.2 PRODUCT PORTFOLIO 126
18.7.3 RECENT DEVELOPMENT 126

18.8 DIGICARE BIOMEDICAL 127
18.8.1 COMPANY SNAPSHOT 127
18.8.2 PRODUCT PORTFOLIO 127
18.8.3 RECENT DEVELOPMENT 127
18.9 GUANGDONG BIOLIGHT MEDICAL TECHNOLOGY CO., LTD. 128
18.9.1 COMPANY SNAPSHOT 128
18.9.2 PRODUCT PORTFOLIO 128
18.9.3 RECENT DEVELOPMENT 128
18.10 HONEYWELL INTERNATIONAL INC. 129
18.10.1 COMPANY SNAPSHOT 129
18.10.2 REVENUE ANALYSIS 129
18.10.3 PRODUCT PORTFOLIO 130
18.10.4 RECENT DEVELOPMENTS 130
18.11 KONINKLIJKE PHILIPS N.V. 131
18.11.1 COMPANY SNAPSHOT 131
18.11.2 REVENUE ANALYSIS 131
18.11.3 PRODUCT PORTFOLIO 132
18.11.4 RECENT DEVELOPMENTS 132
18.12 HISERN MEDICAL 133
18.12.1 COMPANY SNAPSHOT 133
18.12.2 PRODUCT PORTFOLIO 133
18.12.3 RECENT DEVELOPMENT 133
18.13 MEDKE 134
18.13.1 COMPANY SNAPSHOT 134
18.13.2 PRODUCT PORTFOLIO 134
18.13.3 RECENT DEVELOPMENTS 136
18.14 NONIN 137
18.14.1 COMPANY SNAPSHOT 137
18.14.2 PRODUCT PORTFOLIO 137
18.14.3 RECENT DEVELOPMENTS 138
18.15 ORNATECH INC 139
18.15.1 COMPANY SNAPSHOT 139
18.15.2 PRODUCT PORTFOLIO 139
18.15.3 RECENT DEVELOPMENT 140
18.16 PROACT MEDICAL LTD 141
18.16.1 COMPANY SNAPSHOT 141
18.16.2 PRODUCT PORTFOLIO 141
18.16.3 RECENT DEVELOPMENT 141

18.17 SPACELABS HEALTHCARE 142
18.17.1 COMPANY SNAPSHOT 142
18.17.2 PRODUCT PORTFOLIO 142
18.17.3 RECENT DEVELOPMENT 142
18.18 SHENZHEN LONTEK ELECTRONIC TECHNOLOGY CO., LIMITED 143
18.18.1 COMPANY SNAPSHOT 143
18.18.2 PRODUCT PORTFOLIO 143
18.18.3 RECENT DEVELOPMENT 144
18.19 SHENZHEN MED-LINK ELECTRONICS TECH CO., LTD 145
18.19.1 COMPANY SNAPSHOT 145
18.19.2 PRODUCT PORTFOLIO 145
18.19.3 RECENT DEVELOPMENT 146
18.20 SMITHS MEDICAL (ACQUIRED BY ICU MEDICAL, INC.) 147
18.20.1 COMPANY SNAPSHOT 147
18.20.2 REVENUE ANALYSIS 147
18.20.3 PRODUCT PORTFOLIO 148
18.20.4 RECENT DEVELOPMENTS 148
18.21 UNIMED MEDICAL SUPPLIES, INC 149
18.21.1 COMPANY SNAPSHOT 149
18.21.2 PRODUCT PORTFOLIO 149
18.21.3 RECENT DEVELOPMENTS 149
19 QUESTIONNAIRE 150
20 RELATED REPORTS 154